Please login to the form below

Not currently logged in
Email:
Password:

Novartis appoints Shaun Coughlin to lead its US biomedical research institute

The renowned academic joins as the pharma firm's global head of cardiovascular and metabolism

Shaun CoughlinNovartis has appointed Shaun Coughlin to head up its biomedical research institute based in Cambridge, Massachusetts, as its new global head of cardiovascular and metabolism.

He joins the pharma giant from the University of California San Francisco’s (UCSF) cardiovascular research centre, where he was previously a director. He has served UCSF for 33 years.

Talmadge King Jr, dean, school of medicine at USFC, said: “We are sad to lose on our most respected leaders, yet profoundly grateful for his decades of service and immeasurable contributions to our mission.

“Dr Coughlin is an outstanding example of the personal qualities that collectively have propelled UCSGF to the top.”

Coughlin is also a member of the National Academy of Scienes, the National Academy of Medicine and the American Academy of Arts & Scienes and has won numerous awards including Brisol-Myers Squibb’s Cardiovascular Research Award.

23rd August 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics